SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 293 filers reported holding SHOCKWAVE MED INC in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,235,017 | -46.5% | 6,203 | -23.3% | 0.05% | -47.1% |
| Q2 2023 | $2,307,825 | +496.6% | 8,086 | +353.3% | 0.09% | +443.8% |
| Q1 2023 | $386,825 | -79.7% | 1,784 | -80.8% | 0.02% | -86.1% |
| Q4 2022 | $1,906,622 | +37.6% | 9,273 | +86.0% | 0.12% | +33.7% |
| Q3 2022 | $1,386,000 | +463.4% | 4,985 | +321.0% | 0.09% | +760.0% |
| Q1 2022 | $246,000 | -80.9% | 1,184 | -83.6% | 0.01% | -82.8% |
| Q4 2021 | $1,286,000 | -30.1% | 7,211 | -19.3% | 0.06% | -44.8% |
| Q3 2021 | $1,840,000 | -55.7% | 8,936 | -59.2% | 0.10% | -60.7% |
| Q2 2021 | $4,158,000 | +958.0% | 21,913 | +627.0% | 0.27% | +1305.3% |
| Q1 2021 | $393,000 | -73.1% | 3,014 | -78.6% | 0.02% | -69.8% |
| Q4 2020 | $1,461,000 | +43.2% | 14,088 | +4.7% | 0.06% | +31.2% |
| Q3 2020 | $1,020,000 | +74.4% | 13,454 | -23.7% | 0.05% | +14.3% |
| Q1 2020 | $585,000 | – | 17,641 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |